Pronunciation: (proh-KAR-buh-zeen)

The active ingredient in a drug that is used to treat advanced Hodgkin lymphoma and is being studied in the treatment of other types of cancer. Procarbazine blocks cells from making proteins and damages DNA. It may kill cancer cells. It is a type of antineoplastic agent and a type of alkylating agent.

Source: NCI Dictionary of Cancer Terms

Date last modified: 2005-02-17